These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 19773587)

  • 1. Optimizing a kinase assay for IKKbeta on an HTS station.
    Doti N; Marasco D; Pedone C; Sabatella M; Ruvo M
    J Biomol Screen; 2009 Dec; 14(10):1263-8. PubMed ID: 19773587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel scaffolds for IκB kinase beta inhibitor via a high-throughput screening TR-FRET assay.
    Oh KS; Lee S; Choi JK; Lee BH
    Comb Chem High Throughput Screen; 2010 Nov; 13(9):790-7. PubMed ID: 20615197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplexing terbium- and europium-based TR-FRET readouts to increase kinase assay capacity.
    Horton RA; Vogel KW
    J Biomol Screen; 2010 Sep; 15(8):1008-15. PubMed ID: 20460248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fluorescence resonance energy transfer-based binding assay for characterizing kinase inhibitors: important role for C-terminal biotin tagging of the kinase.
    Kwan J; Ling A; Papp E; Shaw D; Bradshaw JM
    Anal Biochem; 2009 Dec; 395(2):256-62. PubMed ID: 19716360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A homogeneous time-resolved fluorescence-based high-throughput screening system for discovery of inhibitors of IKKbeta-NEMO interaction.
    Gotoh Y; Nagata H; Kase H; Shimonishi M; Ido M
    Anal Biochem; 2010 Oct; 405(1):19-27. PubMed ID: 20522330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Novel Phosphorylated AMPK Protection Assay for High-Throughput Screening Using TR-FRET Assay.
    Xu Y; Wang Y; Xu Y; Li J; Liao H; Zhang L; Pang T
    J Biomol Screen; 2015 Aug; 20(7):906-12. PubMed ID: 25956678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Dual Readout Assay Based on Fluorescence Polarization and Time-Resolved Fluorescence Resonance Energy Transfer to Screen for RSK1 Inhibitors.
    Jeong EM; Lee MY; Lee JH; Lee BH; Oh KS
    Biol Pharm Bull; 2016; 39(4):547-55. PubMed ID: 27040627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence polarization and time-resolved fluorescence resonance energy transfer techniques for PI3K assays.
    Horiuchi KY; Ma H
    Methods Mol Biol; 2009; 572():161-76. PubMed ID: 20694691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A colorimetric assay optimization for high-throughput screening of dihydroorotase by detecting ureido groups.
    Rice AJ; Truong L; Johnson ME; Lee H
    Anal Biochem; 2013 Oct; 441(1):87-94. PubMed ID: 23769705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homogeneous single-label tyrosine kinase activity assay for high throughput screening.
    Tong-Ochoa N; Kopra K; Syrjänpää M; Legrand N; Härmä H
    Anal Chim Acta; 2015 Oct; 897():96-101. PubMed ID: 26515010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TR-FRET-based high-throughput screening assay for identification of UBC13 inhibitors.
    Madiraju C; Welsh K; Cuddy MP; Godoi PH; Pass I; Ngo T; Vasile S; Sergienko EA; Diaz P; Matsuzawa S; Reed JC
    J Biomol Screen; 2012 Feb; 17(2):163-76. PubMed ID: 22034497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermally denatured BSA, a surrogate additive to replace BSA in buffers for high-throughput screening.
    Peña I; Domínguez JM
    J Biomol Screen; 2010 Dec; 15(10):1281-6. PubMed ID: 20847192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Time-Resolved Fluorescence Resonance Energy Transfer Ultrahigh-Throughput Screening Assay for Targeting the NSD3 and MYC Interaction.
    Xiong J; Pecchi VG; Qui M; Ivanov AA; Mo X; Niu Q; Chen X; Fu H; Du Y
    Assay Drug Dev Technol; 2018; 16(2):96-106. PubMed ID: 29634317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput TR-FRET assays for identifying inhibitors of LSD1 and JMJD2C histone lysine demethylases.
    Yu V; Fisch T; Long AM; Tang J; Lee JH; Hierl M; Chen H; Yakowec P; Schwandner R; Emkey R
    J Biomol Screen; 2012 Jan; 17(1):27-38. PubMed ID: 21859682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A homogeneous single-label time-resolved fluorescence cAMP assay.
    Martikkala E; Rozwandowicz-Jansen A; Hänninen P; Petäjä-Repo U; Härmä H
    J Biomol Screen; 2011 Mar; 16(3):356-62. PubMed ID: 21343601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform.
    Lebakken CS; Riddle SM; Singh U; Frazee WJ; Eliason HC; Gao Y; Reichling LJ; Marks BD; Vogel KW
    J Biomol Screen; 2009 Sep; 14(8):924-35. PubMed ID: 19564447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of a Universal High-Throughput UDP-Glycosyltransferase Assay with a Time-Resolved FRET Signal.
    Zielinski T; Reichman M; Donover PS; Lowery RG
    Assay Drug Dev Technol; 2016 May; 14(4):240-51. PubMed ID: 27136323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a time-resolved fluorescence resonance energy transfer ultra-high throughput screening assay targeting SYK and FCER1G interaction.
    Du Y; Wang D; Katis VL; Zoeller EL; Qui M; Levey AI; Gileadi O; Fu H;
    SLAS Discov; 2024 Sep; 29(6):100177. PubMed ID: 39154664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of high-throughput screening.
    Entzeroth M; Flotow H; Condron P
    Curr Protoc Pharmacol; 2009 Mar; Chapter 9():Unit 9.4. PubMed ID: 22294406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bioluminogenic HDAC activity assay: validation and screening.
    Halley F; Reinshagen J; Ellinger B; Wolf M; Niles AL; Evans NJ; Kirkland TA; Wagner JM; Jung M; Gribbon P; Gul S
    J Biomol Screen; 2011 Dec; 16(10):1227-35. PubMed ID: 21832257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.